How are we governed?
After three years of reviewing our statutes and consulting our Member Societies, we have updated our governing documents to improve our responsiveness to internal and external change and allow wider community participation in our activities. The new statutes were formally accepted by our Membership on 1 May 2017.
FEMS is registered in the United Kingdom (in actual fact in England and Wales) as a Company (a Company limited by guarantee and not having a share capital; incorporated on 18 May 1998; No. 3565643), and as a Charity (No. 1072117). The registered office of FEMS is situated in Wrexham, UK. For this reason, the statutes adhere to UK format.
The governance of the Federation of European Microbiological Societies is described in two documents that constitute the FEMS Statutes. The statutory documents are the ‘Memorandum of Association’ and the ‘Articles of Association’. These two documents are fairly rigid in that they may only be amended after approval by the FEMS Council and relevant UK-authorities (like the Charity Commissioners).
The statutory documents are available in PDF format under the following links:
The aim of this study was to determine whether in vitro induced erythromycin resistance facilitates the cross-resistance to the novel fluoroketolide, solithromycin, in Staphylococcus aureus. Long-term exposure of erythromycin results in resistance to ketolides in S. aureus through drug binding site mutations. These results demonstrate that since erythromycin has been used clinically for a long time, it is necessary to carefully evaluate the rewards and risks when prescribing solithromycin for the treatment of infectious diseases.